EYPT
Price
$11.72
Change
+$0.16 (+1.38%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
797.49M
57 days until earnings call
LYRA
Price
$7.34
Change
+$0.34 (+4.86%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
11.51M
Interact to see
Advertisement

EYPT vs LYRA

Header iconEYPT vs LYRA Comparison
Open Charts EYPT vs LYRABanner chart's image
EyePoint Pharmaceuticals
Price$11.72
Change+$0.16 (+1.38%)
Volume$18.19K
Capitalization797.49M
Lyra Therapeutics
Price$7.34
Change+$0.34 (+4.86%)
Volume$1.89K
Capitalization11.51M
EYPT vs LYRA Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. LYRA commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (EYPT: $11.57 vs. LYRA: $7.00)
Brand notoriety: EYPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 74% vs. LYRA: 12%
Market capitalization -- EYPT: $797.49M vs. LYRA: $11.51M
EYPT [@Biotechnology] is valued at $797.49M. LYRA’s [@Biotechnology] market capitalization is $11.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 3 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 3 bullish, 4 bearish.
  • LYRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than EYPT.

Price Growth

EYPT (@Biotechnology) experienced а -2.20% price change this week, while LYRA (@Biotechnology) price change was -6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($797M) has a higher market cap than LYRA($11.5M). EYPT YTD gains are higher at: 55.302 vs. LYRA (-32.171). LYRA has higher annual earnings (EBITDA): -35.34M vs. EYPT (-172.05M). EYPT has more cash in the bank: 256M vs. LYRA (29.8M). EYPT has less debt than LYRA: EYPT (21.8M) vs LYRA (32.5M). EYPT has higher revenues than LYRA: EYPT (51.9M) vs LYRA (770K).
EYPTLYRAEYPT / LYRA
Capitalization797M11.5M6,930%
EBITDA-172.05M-35.34M487%
Gain YTD55.302-32.171-172%
P/E RatioN/AN/A-
Revenue51.9M770K6,740%
Total Cash256M29.8M859%
Total Debt21.8M32.5M67%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLYRA
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
MACD
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
Aroon
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMSHX27.120.01
+0.04%
Franklin Mutual Shares R6
RLECX21.61-0.07
-0.32%
Russell Inv US Small Cap Equity C
IVAEX24.22-0.09
-0.37%
Macquarie Asset Strategy Fund Cl I
SCAUX11.74-0.05
-0.42%
Invesco Income Advantage U.S. Fund A
SRIGX14.13-0.07
-0.49%
Gabelli SRI AAA

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-0.26%
OCUL - EYPT
65%
Loosely correlated
-2.48%
LYRA - EYPT
58%
Loosely correlated
-0.71%
ATHE - EYPT
54%
Loosely correlated
-1.63%
BEAM - EYPT
53%
Loosely correlated
-2.91%
RXRX - EYPT
53%
Loosely correlated
-3.39%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-0.71%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
-0.26%
VERA - LYRA
54%
Loosely correlated
-2.92%
KYMR - LYRA
53%
Loosely correlated
-1.32%
CLNN - LYRA
39%
Loosely correlated
-1.66%
More